Jaguar Health, Inc. (JAGX) stock
JAGXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.40−0.08 (-16.67%)
Close on Nov 12, 2026Market cap $2.07MP/E –Yield –
Jaguar Health profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Jaguar Health's profit margin for the twelve months ending Dec 31, 2025 was -465.4%. For fiscal 2025 it was -465.4%, against -329.3% the year before. The highest annual figure on record is -0.4% in fiscal 2022.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -465.4% | −136.1 |
| FY2024 | Dec 31, 2024 | -329.3% | −328.9 |
| FY2023 | Dec 31, 2023 | -0.4% | −0.0 |
| FY2022 | Dec 31, 2022 | -0.4% | +0.8 |
| FY2021 | Dec 31, 2021 | -1.2% | +359.0 |
| FY2020 | Dec 31, 2020 | -360.2% | +307.1 |
| FY2019 | Dec 31, 2019 | -667.3% | +60.6 |
| FY2018 | Dec 31, 2018 | -727.9% | −224.2 |
| FY2017 | Dec 31, 2017 | -503.7% | +9907.1 |
| FY2016 | Dec 31, 2016 | -10410.9% | −4105.6 |
| FY2015 | Dec 31, 2015 | -6305.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | -717.2% | −434.5 |
| Q3 FY2025 | Sep 30, 2025 | -308.2% | +8.8 |
| Q2 FY2025 | Jun 30, 2025 | -349.3% | −0.5 |
| Q1 FY2025 | Mar 31, 2025 | -472.6% | −80.2 |
| Q4 FY2024 | Dec 31, 2024 | -282.7% | −1677.8 |
| Q3 FY2024 | Sep 30, 2024 | -317.1% | −40.6 |
| Q2 FY2024 | Jun 30, 2024 | -348.8% | −8.4 |
| Q1 FY2024 | Mar 31, 2024 | -392.4% | −108.8 |
| Q4 FY2023 | Dec 31, 2023 | 1395.1% | +1686.8 |
| Q3 FY2023 | Sep 30, 2023 | -276.5% | +636.7 |
| Q4 FY2020 | Dec 31, 2020 | -340.4% | +55.0 |
| Q3 FY2020 | Sep 30, 2020 | -283.7% | +492.8 |
| Q2 FY2020 | Jun 30, 2020 | -291.7% | +688.4 |
| Q1 FY2020 | Mar 31, 2020 | -913.2% | −391.0 |
| Q4 FY2019 | Dec 31, 2019 | -395.4% | +397.5 |
| Q3 FY2019 | Sep 30, 2019 | -776.5% | −234.2 |
| Q2 FY2019 | Jun 30, 2019 | -980.1% | +330.3 |
| Q1 FY2019 | Mar 31, 2019 | -522.3% | −954.9 |
| Q4 FY2018 | Dec 31, 2018 | -792.9% | −591.5 |
| Q3 FY2018 | Sep 30, 2018 | -542.2% | +31.1 |
| Q4 FY2017 | Dec 31, 2017 | -1310.4% | +11421.5 |
| Q3 FY2017 | Sep 30, 2017 | 432.6% | +7215.2 |
| Q2 FY2017 | Jun 30, 2017 | -201.4% | – |
| Q1 FY2017 | Mar 31, 2017 | -573.4% | – |
| Q4 FY2016 | Dec 31, 2016 | -12732.0% | – |
| Q3 FY2016 | Sep 30, 2016 | -6782.6% | – |
See a number that looks wrong?